Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19 K Steuten, H Kim, JC Widen, BM Babin, O Onguka, S Lovell, O Bolgi, ... ACS infectious diseases 7 (6), 1457-1468, 2021 | 83 | 2021 |
Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody MJ Van Elsas, JMS Van der Schoot, A Bartels, K Steuten, D Van Dalen, ... International journal of molecular sciences 23 (15), 8707, 2022 | 4 | 2022 |